Disseminated tumor cells predict survival after neoadjuvant therapy in primary breast cancer (Q84475392)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717428%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Disseminated tumor cells predict survival after neoadjuvant therapy in primary breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717428%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author

Anirban Bhattacharyya

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717428%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Carolyn Hall

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717428%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Savitri Krishnamurthy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717428%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Ashutosh Lodhi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717428%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Amber Anderson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717428%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Henry Kuerer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717428%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Isabelle Bedrosian

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717428%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Balraj Singh

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717428%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Anthony Lucci

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717428%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

29 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717428%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717428%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717428%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717428%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

342-348

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717428%20AND%20SRC:MED&resulttype=core&format=json

Preoperative therapy in breast cancer: lessons from the treatment of locally advanced disease

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

Primary systemic therapy of breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

Feasibility and tolerability of sequential doxorubicin/paclitaxel followed by cyclophosphamide, methotrexate, and fluorouracil and its effects on tumor response as preoperative therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

A pooled analysis of bone marrow micrometastasis in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

Monitoring of disseminated tumor cells in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

Disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

Presence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

Biological characteristics of micrometastatic cancer cells in bone marrow

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

Estrogen receptor expression profile of disseminated epithelial tumor cells in bone marrow of breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26202

7 January 2021

Identifiers

DOI

10.1002/CNCR.26202

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717428%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference